Skin Exposome: Companies, Startups & Research

FACTS identifies 337 companies in the field, including L'Oréal and Mary Kay Inc. among the patent holders. L'Oréal works on methods combining geolocation and environmental data to estimate skin-condition risks, as well as UV damage and photoprotection. The company landscape also spans product and skincare activity, so company involvement does not necessarily mean each organization develops exposome-specific technology.

FACTS identifies 15 startups, including Oxiproteomics Sas, which is associated with research on skin aging and a rose-derived PDRN ingredient. Its work investigates molecular targets in the context of UV and pollution-related stress. The available information does not provide comparative performance or commercial-readiness evidence, so it cannot establish which startup is most promising.

FACTS lists 2,107 research organizations, with recent work from the University of São Paulo, Fudan University and the University of Manchester. Their research includes UV-related skin damage, photoprotection, solar UV patterns and photoaging mechanisms. Other recent studies include work from Shihezi University on air pollution and atopic dermatitis and from Army Medical University on a single-cell atlas of photoaged skin.

FACTS records $17,419,104 in grants across 36 grants since 2020 and $3,639,772,379 across 36 funding rounds. These are recorded landscape-level totals, not verified totals for skin-exposome-specific projects. The funding entries may include activity from organizations whose reported financing is not directly tied to this topic, so the figures should be treated as broad indicators.

L'Oréal leads the listed patent holders with 7 patents, followed by Mary Kay Inc. with 4 and Shenzhen Winkey Technology Co with 3. RIKEN, the University of Porto, AGC Inc. and Sytheon Ltd. each have 2 listed patents. These counts identify patent holders in the topic data and do not describe the scope or legal status of each patent.

No: patent activity is down 62.5% in the 12-month comparison reported by FACTS. The dataset lists 88 patents in the 24-month window, while publication activity is increasing. This contrast suggests that research output and patenting are not moving in step; it does not establish why activity changed or predict future patent filings.

Recent developments include a September 2026 study of broad-molecular-weight hyaluronic acid for barrier protection and a September 2026 study of ST6GAL1 in UVA-induced photoaging. In August 2026, researchers reported a single-cell atlas of photoaged skin and a 40-location study of European solar UV trends. These results connect exposure measurement with skin mechanisms and potential interventions.

FACTS groups the field into 6 approaches: solar radiation, air pollution, chemical exposures, lifestyle and behavioral factors, psychosocial and climatic stressors, and exposure assessment and mechanisms. They differ in the stressors measured and the biological or behavioral pathways studied. Solar radiation has the largest listed patent share, while exposure assessment and mechanisms focuses on connecting external exposures to skin responses.

The United States leads the country list with 11,022 documents, followed by China with 4,038 and the United Kingdom with 3,672. Germany and India are also among the leading countries in the FACTS data. These counts indicate recorded activity, rather than the quality of research, commercial strength or the location of every organization working on the topic.

FACTS identifies 5 application areas: dermatology and disease prevention, cosmetics and skincare, occupational health, public and environmental health, and clinical and population research. Dermatology and disease prevention has the largest listed document count, while cosmetics and skincare activity is growing. Applications range from studying environmental contributions to skin disease to developing skincare and informing exposure-related prevention.